Drugs / Dactavira Plus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03186313 | Sep 2016 → May 2017 | chronic hepatitis C virus infection | Egyptian Liver Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dactavira Plus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03186313 ↗ |